Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord

Nuclear magnetic resonance (MR) imaging provides a noninvasive method for studying the fate of transplanted cells in vivo. We studied, in animals with a cortical photochemical lesion or with a balloon‐induced spinal cord compression lesion, the fate of implanted rat bone marrow stromal cells (MSCs)...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroscience research Vol. 76; no. 2; pp. 232 - 243
Main Authors Jendelová, Pavla, Herynek, Vít, Urdzíková, Lucia, Glogarová, Kateřina, Kroupová, Jana, Andersson, Benita, Bryja, Vítězslav, Burian, Martin, Hájek, Milan, Syková, Eva
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.04.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nuclear magnetic resonance (MR) imaging provides a noninvasive method for studying the fate of transplanted cells in vivo. We studied, in animals with a cortical photochemical lesion or with a balloon‐induced spinal cord compression lesion, the fate of implanted rat bone marrow stromal cells (MSCs) and mouse embryonic stem cells (ESCs) labeled with superparamagnetic iron oxide nanoparticles (Endorem). MSCs were colabeled with bromodeoxyuridine (BrdU), and ESCs were transfected with pEGFP‐C1 (eGFP ESCs). Cells were either grafted intracerebrally into the contralateral hemisphere of the adult rat brain or injected intravenously. In vivo MR imaging was used to track their fate; Prussian blue staining and electron microscopy confirmed the presence of iron oxide nanoparticles inside the cells. During the first week postimplantation, grafted cells migrated to the lesion site and populated the border zone of the lesion. Less than 3% of MSCs differentiated into neurons and none into astrocytes; 5% of eGFP ESCs differentiated into neurons, whereas 70% of eGFP ESCs became astrocytes. The implanted cells were visible on MR images as a hypointense area at the injection site, in the corpus callosum and in the lesion. The hypointense signal persisted for more than 50 days. The presence of GFP‐positive or BrdU‐positive and nanoparticle‐labeled cells was confirmed by histological staining. Our study demonstrates that both grafted MSCs and eGFP ESCs labeled with a contrast agent based on iron oxide nanoparticles migrate into the injured CNS. Iron oxide nanoparticles can therefore be used as a marker for the long‐term noninvasive MR tracking of implanted stem cells. © 2004 Wiley‐Liss, Inc.
Bibliography:Grant Agency of the Czech Republic - No. 304/03/1189
Academy of Sciences of the Czech Republic - No. AVOZ5039906-1024
Ministry of Education, Sports and Youth of the Czech Republic - No. LN00A065; No. J13/98: 11120004
ArticleID:JNR20041
istex:3D902FD8DC9B87CBB8283F92EF16F70CF7AF6B36
ark:/67375/WNG-NT335JHM-F
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0360-4012
1097-4547
DOI:10.1002/jnr.20041